BTMD
biote Corp.
NASDAQ · Healthcare · Medical - Care Facilities · US
$1.17
+4.48%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.18
From 52W high−60.06%
Volume14909.00
Market cap$33.56M
P/E (TTM)7.0x
P/S (TTM)0.2x
Div yield—
Key dataNov 4, 2026
Open
$1.18
From 52W high
−60.06%
Volume
14909.00
Market cap
$33.56M
ValuationView details →
P/E (Fwd)
5.3x
EV/EBITDA
6.8x
P/E (TTM)
7.0x
RSI (14)
49.8
MomentumView details →
1D Return
+4.48%
YTD Return
−55.00%
SummaryUpdated Jun 1, 2026
Biote Corp. (NASDAQ:BTMD) is a medical practice-building company that operates within the hormone optimization healthcare sector. Founded in 2011 and headquartered in Irving, Texas, the company went public in April 2021. Biote has established itself as a leading provider of bioidentical hormone replacement therapy solutions, serving a network of over 8,600 healthcare providers across the United States. The company operates through a franchise-like model, providing practitioners with training, certification, proprietary software, and products needed to offer hormone optimization treatments to patients.
Similar companies
Latest newsMore news →
Biote announced that it will release its third-quarter 2026 financial results after market close on November 4, 2026, and hold a conference call at 5:00 p.m. ET that day.14d agoMarc Beer was appointed Executive Chairman of the Board of biote Corp., effective June 8, 2026.156d agoRobert Peterson was appointed Interim Chief Executive Officer and Director of biote Corp., effective June 8, 2026.156d ago